8.80
price down icon8.62%   -0.83
pre-market  시장 영업 전:  8.80  
loading

Phathom Pharmaceuticals Inc 주식(PHAT)의 최신 뉴스

pulisher
Jul 28, 2025

What are the latest earnings results for Phathom Pharmaceuticals Inc.High-octane financial growth - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Phathom Pharmaceuticals to Host Conference Call for Q2 2025 Financial Results on August 7, 2025 - Quiver Quantitative

Jul 28, 2025
pulisher
Jul 28, 2025

Phathom Pharmaceuticals to Report Second Quarter 2025 Financial Results and Provide Business Update on Thursday, August 7, 2025 - The Manila Times

Jul 28, 2025
pulisher
Jul 28, 2025

Phathom Pharmaceuticals to Report Second Quarter 2025 - GlobeNewswire

Jul 28, 2025
pulisher
Jul 28, 2025

What is Phathom Pharmaceuticals Inc. company’s growth strategyInvest with confidence backed by data - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Is it the right time to buy Phathom Pharmaceuticals Inc. stockAI Powered Review For 2025 - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How does Phathom Pharmaceuticals Inc. generate profit in a changing economyTop Growth Planner That Work - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

What are the technical indicators suggesting about Phathom Pharmaceuticals Inc.Rapid market gains - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is Phathom Pharmaceuticals Inc. a growth stock or a value stockDiscover hidden gems in the stock market - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What makes Phathom Pharmaceuticals Inc. stock price move sharplyFree Real-Time Market Predictions - metal.it

Jul 27, 2025
pulisher
Jul 27, 2025

How many analysts rate Phathom Pharmaceuticals Inc. as a “Buy”Discover undervalued opportunities early - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What is the risk reward ratio of investing in Phathom Pharmaceuticals Inc. stockMaximize profits with strategic stock selection - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 23, 2025

What analysts say about Phathom Pharmaceuticals Inc. stockFree Capital Allocation Plans - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Is Phathom Pharmaceuticals Inc. a good long term investmentFree Daily Trading Room Entry - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Phathom Pharmaceuticals Inc. Stock Analysis and ForecastConsistent triple returns - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

What drives Phathom Pharmaceuticals Inc. stock priceBreakout portfolio performance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 19, 2025

Why We're Not Concerned Yet About Phathom Pharmaceuticals, Inc.'s (NASDAQ:PHAT) 27% Share Price Plunge - simplywall.st

Jul 19, 2025
pulisher
Jul 18, 2025

Phathom Pharmaceuticals' Principal Accounting Officer Robert Charles Sells 1692 Shares at $8.36. - AInvest

Jul 18, 2025
pulisher
Jul 17, 2025

When Will Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Turn A Profit? - 富途牛牛

Jul 17, 2025
pulisher
Jul 16, 2025

Analysts Set Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Target Price at $17.50 - Defense World

Jul 16, 2025
pulisher
Jul 16, 2025

Why Phathom Pharmaceuticals Inc. stock attracts strong analyst attentionShort Squeeze Radar - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

How Phathom Pharmaceuticals Inc. stock performs during market volatilityGrowth Stock Monitor - Newser

Jul 15, 2025
pulisher
Jul 07, 2025

How To Trade (PHAT) - news.stocktradersdaily.com

Jul 07, 2025
pulisher
Jul 02, 2025

Phathom Pharmaceuticals, Inc.'s (NASDAQ:PHAT) Profit Outlook - simplywall.st

Jul 02, 2025
pulisher
Jun 28, 2025

Phathom Pharmaceuticals: A Path to Profitability and a Billion-Dollar Horizon with Voquezna? - AInvest

Jun 28, 2025
pulisher
Jun 27, 2025

Phathom Pharmaceuticals shares rise 1.47% premarket after Cidara Therapeutics closes $402.5 million stock offering. - AInvest

Jun 27, 2025
pulisher
Jun 25, 2025

Phathom Pharmaceuticals: Potential Blockbuster Gastric Acid-Reducing Drug With New Mechanism - Seeking Alpha

Jun 25, 2025
pulisher
Jun 23, 2025

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jun 23, 2025
pulisher
Jun 23, 2025

Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary - GlobeNewswire

Jun 23, 2025
pulisher
Jun 17, 2025

FDA Approval for VOQUENZA TRIPLE PAK issued to PHATHOM PHARMACEUTICALS, INC - Quantisnow

Jun 17, 2025
pulisher
Jun 17, 2025

Phathom says FDA confirmed Voqueza exclusivity through May 2032 - MSN

Jun 17, 2025
pulisher
Jun 16, 2025

Phathom Pharmaceuticals Announces FDA Correction to Orange - GlobeNewswire

Jun 16, 2025
$23.09
price down icon 1.32%
$37.06
price up icon 1.06%
$101.75
price down icon 2.12%
$27.45
price down icon 4.26%
$112.79
price down icon 2.19%
biotechnology ONC
$294.51
price up icon 1.04%
자본화:     |  볼륨(24시간):